Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Can Cannabis Cannabinoids Change Chemoreceptor Sensitivity in Sleep Apnoea? 

Posted
Updated
ByMy Patient Advice
Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Chemoreceptors play a critical role in detecting blood oxygen and carbon dioxide levels, influencing breathing stability during sleep. Researchers are exploring whether cannabinoids for chemoreceptors can modify this sensitivity to improve respiratory control in sleep apnoea . 

Am I eligible for medical cannabis for pain relief?

Chemoreceptor Modulation 

Evidence suggests cannabinoids for chemoreceptors may impact chemoreceptor response with cannabinoids, potentially altering ventilatory drive and stabilising breathing patterns. 

Mechanism of Action 

By interacting with central and peripheral chemoreceptors, cannabinoids for chemoreceptors could adjust respiratory chemosensitivity, helping the body respond more effectively to drops in oxygen or rises in carbon dioxide. 

Potential Benefits 

Modifying chemoreceptor response with cannabinoids may reduce the frequency of apnoeic events, improve nocturnal oxygen levels, and enhance overall sleep quality for patients with sleep apnoea. 

Research Considerations 

Current studies are limited, and more controlled research is required to clarify which cannabinoids, doses, and timing best influence respiratory chemosensitivity without causing unwanted side effects. 

Preliminary findings indicate cannabinoids for chemoreceptors could play a role in modulating respiratory chemosensitivity, potentially supporting breathing stability in sleep apnoea. Further trials are needed to determine safe and effective clinical applications. 

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea  

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories